261 related articles for article (PubMed ID: 16202694)
1. Clinical pharmacology of antihypertensive therapy.
Taylor AA; Pool JL
Semin Nephrol; 2005 Jul; 25(4):215-26. PubMed ID: 16202694
[TBL] [Abstract][Full Text] [Related]
2. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
3. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
4. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
Neutel JM
Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
[TBL] [Abstract][Full Text] [Related]
5. [Success of blood pressure reduction in diabetic patients].
Schernthaner G
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S247-51. PubMed ID: 17139580
[TBL] [Abstract][Full Text] [Related]
6. Outcomes from treatment. Clinical applications from recent trials.
Howes LG
Aust Fam Physician; 1999 Jul; 28(7):707-10. PubMed ID: 10431429
[TBL] [Abstract][Full Text] [Related]
7. Issues in blood pressure control and the potential role of single-pill combination therapies.
Burnier M; Brown RE; Ong SH; Keskinaslan A; Khan ZM
Int J Clin Pract; 2009 May; 63(5):790-8. PubMed ID: 19220523
[TBL] [Abstract][Full Text] [Related]
8. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
[TBL] [Abstract][Full Text] [Related]
9. Aliskiren: renin inhibitor for hypertension management.
Cheng JW
Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
[TBL] [Abstract][Full Text] [Related]
10. Multiple drug therapy in the treatment of essential hypertension.
Hockenberry B
Nurs Clin North Am; 1991 Jun; 26(2):417-36. PubMed ID: 2047290
[TBL] [Abstract][Full Text] [Related]
11. [The rationale for drug combinations in the therapy of arterial hypertension].
Salvetti A; Virdis A; Di Venanzio L
Ann Ital Med Int; 1993 Oct; 8 Suppl():107S-110S. PubMed ID: 8117517
[TBL] [Abstract][Full Text] [Related]
12. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
14. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
15. [The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension].
Widimský J
Vnitr Lek; 2009 Feb; 55(2):123-30. PubMed ID: 19348394
[TBL] [Abstract][Full Text] [Related]
16. The need for combination antihypertensive therapy to reach target blood pressures: what has been learned from clinical practice and morbidity-mortality trials?
Struijker-Boudier HA; Ambrosioni E; Holzgreve H; Laurent S; Mancia G; Ruilope LM; Waeber B
Int J Clin Pract; 2007 Sep; 61(9):1592-602. PubMed ID: 17686100
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
Abe M; Okada K; Matsumoto K
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
[TBL] [Abstract][Full Text] [Related]
18. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension.
White WB
Blood Press Monit; 2008 Apr; 13(2):123-9. PubMed ID: 18347448
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic implications of recent megatrials in hypertension: in favor of new drugs.
Volpe M; Tocci G
J Nephrol; 2007; 20 Suppl 12():S12-8. PubMed ID: 18050137
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular prevention (VI). Use of drugs in the primary prevention of arterial hypertension and dyslipidemia.
González-Juanatey JR; Mazón Ramos P
Rev Esp Cardiol; 2008 Aug; 61(8):861-79. PubMed ID: 18684369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
